Buy or sell Bolt Biotherapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Bolt Biotherapeutics Stock

Bolt Therapeutics plans to develop a novel format for T-cell mediated anti-tumour therapy.

About Bolt Biotherapeutics Stock

Bolt Therapeutics plans to develop a novel format for T-cell mediated anti-tumour therapy.

Funding History

March 2015$600K
September 2016$10.0M
August 2018$19.4M
February 2019$54.0M

Management

President and CEO

Reiner Laus

Chief Business Officer

Grant Yonehiro

Chief Executive Officer and Director

CP Liu

Founder

Edgar Engleman

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Bolt Biotherapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 110K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo